BlueOcean and Neptune Amend Licensing Agreement.
Saved in:
| Title: | BlueOcean and Neptune Amend Licensing Agreement. |
|---|---|
| Authors: | Marketwired |
| Source: | Marketwire (English). 03/25/2015. |
| Abstract: | TORONTO, ONTARIO -- (Marketwired) -- 03/25/15 -- BlueOcean NutraSciences Inc. ("BlueOcean") (TSX VENTURE: BOC) announces the signing of an amendment to its exclusive world-wide, royalty-bearing, non-transferable, License Agreement ("License") under Neptune's composition and extraction patents on the production and sale of marine derived oil products containing phospholipids. In addition to the three species of Northern Coldwater shrimp that have already been granted in the License, the amendment to the License allows BlueOcean and its shrimp joint venture affiliate to produce and sell shrimp oil products extracted from an additional seven species of shrimp (Penaeus monodon, Penaeus indicus/Fenneropenaeus indicus, Penaeus vannamei, Metapenaeus dobsoni, Parapenaeopsis stylifera, Metapenaeus monoceros and Metapenaeus affinis), in the nutraceutical, dietary ingredients, natural health products, functional food and food supplements markets. The medical food, drugs and drug product markets are not included. [ABSTRACT FROM PUBLISHER] |
| Database: | Newspaper Source Plus |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | TORONTO, ONTARIO -- (Marketwired) -- 03/25/15 -- BlueOcean NutraSciences Inc. ("BlueOcean") (TSX VENTURE: BOC) announces the signing of an amendment to its exclusive world-wide, royalty-bearing, non-transferable, License Agreement ("License") under Neptune's composition and extraction patents on the production and sale of marine derived oil products containing phospholipids. In addition to the three species of Northern Coldwater shrimp that have already been granted in the License, the amendment to the License allows BlueOcean and its shrimp joint venture affiliate to produce and sell shrimp oil products extracted from an additional seven species of shrimp (Penaeus monodon, Penaeus indicus/Fenneropenaeus indicus, Penaeus vannamei, Metapenaeus dobsoni, Parapenaeopsis stylifera, Metapenaeus monoceros and Metapenaeus affinis), in the nutraceutical, dietary ingredients, natural health products, functional food and food supplements markets. The medical food, drugs and drug product markets are not included. [ABSTRACT FROM PUBLISHER] |
|---|
